Stock Comparison
AstraZeneca PLC vs Pfizer Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AstraZeneca PLC
AZN · London Stock Exchange
Weighted across the company's segments.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisPfizer Inc.
PFE · New York Stock Exchange
Weighted across the company's segments.
Comparison highlights
- Moat score gap: AstraZeneca PLC leads (69 / 100 vs 58 / 100 for Pfizer Inc.).
- Segment focus: AstraZeneca PLC has 6 segments (46% in Oncology); Pfizer Inc. has 5 segments (37.5% in Primary Care).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: AstraZeneca PLC has 1 moat types across 1 domains; Pfizer Inc. has 1 across 1.
Primary market context
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
46%
Pfizer Inc.
Primary Care
Branded primary care medicines and vaccines (incl. cardiovascular, migraine, pneumococcal/RSV/COVID-19)
Global
Healthcare providers, payers/PBMs, pharmacies/wholesalers, and government procurement
Innovator biopharma (R&D + manufacturing + commercialization)
37.5%
Side-by-side metrics
Moat coverage
Shared moat types
AstraZeneca PLC strengths
No unique moat types yet.
Pfizer Inc. strengths
No unique moat types yet.
Segment mix
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Infectious Disease
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
Pfizer Inc. segments
Full profile >Primary Care
Oligopoly
Specialty Care
Oligopoly
Oncology
Competitive
Hospital and Biosimilars
Competitive
Pfizer CentreOne
Competitive
Act on this comparison
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.